Transaction · 0001415889-25-002980

Howe Jolanda

Howe Jolanda, SVP, CTRL, reported an open-market or private sale at Mirum Pharmaceuticals, Inc. involving 1064.000000 shares for an estimated $51308.74. Reported holdings after the transaction were 4232.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SSVP, CTRL
MIRMMirum Pharmaceuticals, Inc.
Filing timeFeb 04
Trade dateFeb 03, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

MIRM price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MIRM since 2025-02-04Filed 577 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001415889-25-002980
Common Stock
Transaction date
Feb 03, 2025
Filed Feb 04, 2025, 10:30 PM · 1d delay
Shares
1.06k sh
$4.82k per share
Estimated value
-$5.13M
Computed from shares × price
Holdings after
4.23k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Holdings Reduction Repeat Seller
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP, GLOBAL CONTROLLER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).

  2. F2

    Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.

  3. F3

    The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and…

Original filing · 0001415889-25-002980
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MIRM